TELIX PHARMACEUTICALS LIMITED

1.52%

$20.73

Market Cap $7.123B

Healthcare Biotechnology

Telix Pharmaceuticals Limited is an Australia-based biopharmaceutical company focused on... Telix Pharmaceuticals Limited is an Australia-based biopharmaceutical company focused on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals and associated medical technologies. It is developing a portfolio of clinical and commercial stage products that aims to address significant unmet medical needs in oncology and rare diseases. Its segments include Therapeutics, Precision Medicine and Telix Manufacturing Solutions. Therapeutics segment develops targeted radionuclide therapies for urologic, neurologic, musculoskeletal and hematological cancers. Precision Medicine segment focuses on bringing diagnostic imaging solutions to market. Precision Medicine segment also includes MedTech and International businesses. Telix Manufacturing Solutions segment is its global network of facilities designed to deliver patient doses worldwide. Its pipeline products include TLX591, TLX250, TLX101, TLX66, TLX592, TLX252, TLX400, Illuccix (68Ga-PSMA-11) and TLX007-CDx.More

Race Oncology (ASX: RAC) is an ASX-listed clinical stage biopharmaceutical company with a dedicated mission to be at the heart of cancer care. LATEST: Race Oncology Accelerates Game-Changing Cancer Drug.

Latest Threads

Tag

Subject

TLX

Ann: Telix Reports US$204M Q2 Revenue, Up 63% YOY

4 5 6

10:52

319

132K

10:52

Last post spnc

319

132K

TLX

Telix Intelligence

5 6 7

31/07/25

364

121K

31/07/25

Last post THE POINT

364

121K

TLX

Telix sinks as US regulator SEC issues subpoena over claims

31/07/25

9.7K

31/07/25

Last post Global123

9.7K

TLX

Telix ASX TLX Breaking News & Current Commentary

56 57 58

31/07/25

3.4K

1.4M

31/07/25

Last post simons77

3.4K

1.4M

TLX

Ann: Telix H1 2025 Results - Investor Webcast Notification

30/07/25

820

30/07/25

Last post spnc

820

TLX

SEC US TOP 100

24/07/25

1.2K

24/07/25

Last post tony123

1.2K

TLX

Ann: Pending Release of Shares from Voluntary Escrow

23/07/25

590

23/07/25

Last post

ASX News

590

TLX

Market competitor news

2 3

15/07/25

141

69K

15/07/25

Last post mnbvcxz12345

141

69K

See All Discussions

Timeline

Telix H1 2025 Results - Investor Webcast Notification
30 Jul 08:29	Share

Pending Release of Shares from Voluntary Escrow
23 Jul 08:40	Share

Telix Reports US$204M Q2 Revenue, Up 63% YOY
22 Jul 16:35	Share

Gozellix Receives Permanent HCPCS Code
09 Jul 11:41	Share

Application for quotation of securities - TLX
09 Jul 08:28	Share

Notification of cessation of securities - TLX
09 Jul 08:06	Share

Application for quotation of securities - TLX
20 Jun 08:20	Share

App 3Y - Change in Director Interests - C Behrenbruch
18 Jun 08:23	Share

Notification regarding unquoted securities - TLX
18 Jun 08:22	Share

Telix Investor Day Presentation
11 Jun 16:48	Share

Notification regarding unquoted securities - TLX
05 Jun 08:23	Share

Application for quotation of securities - TLX
05 Jun 08:23	Share

Notification regarding unquoted securities - TLX
05 Jun 08:23	Share

Notification regarding unquoted securities - TLX
05 Jun 08:23	Share

App 3Z Final Director Interests - K McCann
22 May 08:19	Share

Telix Results of Annual General Meeting
21 May 14:43	Share

Telix Annual General Meeting Presentation
21 May 10:03	Share

Telix Annual General Meeting Chairman and CEO Addresses
21 May 10:02	Share

Pending Release of Shares from Voluntary Escrow
19 May 08:23	Share

Application for quotation of securities - TLX
16 May 17:37	Share

Notification of cessation of securities - TLX
16 May 17:30	Share

Notification regarding unquoted securities - TLX
09 May 08:30	Share

Cleansing Notice
06 May 08:21	Share

Application for quotation of securities - TLX
06 May 08:21	Share

App 3Z Final Director Interests - A Whitaker
01 May 09:12	Share

Anne Whitaker Board Resignation
29 Apr 08:26	Share

Telix Provides Regulatory Update on TLX101-CDx
28 Apr 08:33	Share

Pending Release of Shares from Voluntary Escrow
24 Apr 08:20	Share

Telix Reports US$186M Q1 Revenue, Up 62% YOY
22 Apr 17:01	Share

View More

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last $20.73		Change -0.320(1.52%)		Mkt cap ! $7.123B

Open	High	Low	Value	Volume
$20.90	$21.05	$20.63	$5.614M	270.5K

Buyers (Bids)

No.	Vol.	Price($)
5	187	$20.73

Sellers (Offers)

Price($)	Vol.	No.
$20.74	400	6

View Market Depth

No.	Vol.	Price($)
5	3464	20.700
5	489	20.690
4	611	20.680
6	1849	20.670
4	715	20.660

Price($)	Vol.	No.
20.710	125	1
20.720	273	5
20.730	710	6
20.740	847	7
20.750	695	5

Last trade - 10.32am 01/08/2025 (20 minute delay)


Last $20.61		Change -0.320 ( 1.99 %)
Open	High	Low	Volume
$20.94	$20.97	$20.59	56977
Last updated 10.52am 01/08/2025 ?

TLX (ASX) Chart

TELIX PHARMACEUTICALS LIMITED

Latest Threads

Redcastle Resources Delivers Positive Scoping Study for Queen Alexandra

Timeline

Featured News

Latest Articles

Telix sinks as US regulator SEC issues subpoena over claims

Telix Pharma (ASX:TLX), the ASX listed healthcare major that once almost listed on the NASDAQ outright before...

Telix dips as FDA knocks back new drug for imaging rare brain cancer – despite prior approval

Telix copped a sharp jab on Monday as the FDA said its drug TLX101-CDx can't be accepted for imaging the rare brain cancer glioma.

Telix clocks +150% year-on-year returns as radiopharma acquisition well received

Telix Pharmaceuticals (ASX:TLX) has joined a somewhat quiet cohort of ASX biotech companies having a pretty good run lately.

Buyers (Bids)

Sellers (Offers)

Codeifai looks to ride AI wave as Quantum Computing becomes a necessity

Prospect Resources: Replicating the success of Arcadia with ~1b tonne copper ore target

Infini Resources appoints Rohan Bone as CEO ahead of Phase 2 campaign

Resolution Minerals appoints industry experts to fast-track US growth strategy

Top Stories

Featured News